Wei Xiong

17PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersMajor global burdens of diseaseArtificial life and complex adaptive systemsHaematological tumoursRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 14, 2026
Extended Anticoagulation Therapy with Rivaroxaban for Cancer-Associated Low-Risk Pulmonary Embolism According to Status of Concomitant Deep Vein Thrombosis: Insights from the ONCO PE Randomized Trial.

|May 15, 2026
Extended Rivaroxaban Therapy for Cancer-Associated Low-Risk Pulmonary Embolism by Chemotherapy Status: Insights from the ONCO PE Trial.

|Mar 02, 2026
POLE: Development and Validation of a Pulmonary Embolism Prediction Model in Lung Cancer.

Dongmei Wang, Wei Xiong, Xuan Huang

|Feb 27, 2026
Extended Anticoagulation Therapy With Rivaroxaban for Cancer-Associated Low-Risk Pulmonary Embolism According to Different Performance Status Scores: Insights From the ONCO PE Randomized Trial.

Wei Xiong, Yugo Yamashita, Takeshi Morimoto

|Jul 29, 2025
Adjuvant therapeutic efficacy of low-dose aspirin on short-term outcomes of patients with cancer-associated venous thromboembolism.

Wei Xiong, Zhenzhong Deng, Yi Cheng

|Jul 10, 2025
Optimal threshold of time interval from symptom onset to diagnosis for identification of severity and outcomes in acute symptomatic pulmonary embolism.

Wei Xiong, Qiangqiang Qin, Xiaoyang Song

Pageof 3

Frequent Collaborators

2 joint publications

Yugo Yamashita

2 joint publications

Jianmin Qu

2 joint publications

Ryuki Chatani

1 joint publications

Yi Cheng